Along with these reports, our finding of activating FGFR3 mutations in lung adenocarcinoma patients provides an interesting convergence with mouse genetic experiments wherein activated FGF9-FGFR3 signal acts as the primary oncogenic pathway involved in initiation of lung adenocarcinoma [31, 32]. Here, FGFR3 is linked to lung adenocarcinoma.